HS-20094
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US
Regeneron · Phase 2 · Active, not recruiting · Enrollment 120
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| General Cohort | Obesity or overweight | n/r | n/r | n/r | n/r |
| Subgroup Cohort | Obesity or overweight | n/r | n/r | n/r | n/r |